The Commission on Human Medicines (CHM) has temporarily restricted use of the IXCHIQ Chikungunya vaccine in people aged 65 years and over following very rare fatal reactions reported globally. This is a precautionary measure…
UK Drug Safety Update · June 18, 2025
IXCHIQ Chikungunya vaccine: temporary suspension in people aged 65 years or older
CHM temporarily restricts IXCHIQ Chikungunya vaccine use in people aged 65+ following very rare fatal reactions reported globally.
Published by UK Drug Safety Update. HealthSignal links to the original document; the summary above is extracted from the source text.